Eikon IPO analysis: Big biotech names, big valuation cut
Eikon IPO 分析：大牌生物科技公司，估值大幅下调

For Eikon Therapeutics, its IPO feels more like something it’s surviving rather than celebrating.
对于伊科恩治疗公司而言，这次IPO更像是一场需要熬过去的考验，而非值得庆祝的时刻。